Meningitis News and Research RSS Feed - Meningitis News and Research Twitter

Meningitis is an infection of the fluid of a person's spinal cord and the fluid that surrounds the brain. People sometimes refer to it as spinal meningitis. Meningitis is usually caused by a viral or bacterial infection. Knowing whether meningitis is caused by a virus or bacterium is important because the severity of illness and the treatment differ. Viral meningitis is generally less severe and resolves without specific treatment, while bacterial meningitis can be quite severe and may result in brain damage, hearing loss, or learning disability. For bacterial meningitis, it is also important to know which type of bacteria is causing the meningitis because antibiotics can prevent some types from spreading and infecting other people. Before the 1990s, Haemophilus influenzae type b (Hib) was the leading cause of bacterial meningitis, but new vaccines being given to all children as part of their routine immunizations have reduced the occurrence of invasive disease due to H. influenzae. Today, Streptococcus pneumoniae and Neisseria meningitidis are the leading causes of bacterial meningitis.
Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

In a remarkable series of experiments on a fungus that causes cryptococcal meningitis, a deadly infection of the membranes that cover the spinal cord and brain, investigators at UC Davis have isolated a protein that appears to be responsible for the fungus' ability to cross from the bloodstream into the brain. [More]
New device designed to detect foodborne bacteria

New device designed to detect foodborne bacteria

A new device designed to sample and detect foodborne bacteria is being trialled by scientists at the University of Southampton. [More]
Canadian invasive pneumococcal disease outbreak characterised

Canadian invasive pneumococcal disease outbreak characterised

Canadian scientists have reported details of an outbreak of serotype 12F invasive pneumococcal disease that occurred in Winnipeg between 2009 and 2011 and predominantly affected people who were homeless and/or engaged in illegal drug use. [More]
Researchers explain how meningitis-causing bacteria evade body's immune system

Researchers explain how meningitis-causing bacteria evade body's immune system

Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life. [More]
Biótica researchers develop automated laboratory system that rapidly detects E. coli bacterium

Biótica researchers develop automated laboratory system that rapidly detects E. coli bacterium

A Castellón-based biotechnology R&D project by Biótica has been successfully certified by the Centre for Technological and Industrial Development (CDTI, in Spanish), of the Spanish Ministry of Economy and Competitiveness. [More]
Depression is the leading cause of illness in adolescents, shows WHO's report

Depression is the leading cause of illness in adolescents, shows WHO's report

WHO's "Health for the world's adolescents" report reveals that depression is the predominant cause of illness and disability for both boys and girls aged 10 to 19 years. [More]
State highlights: Budget surplus in Calif., but higher Medi-Cal costs; court-ordered mental health care in Calif.; nurses' authority in Minn.

State highlights: Budget surplus in Calif., but higher Medi-Cal costs; court-ordered mental health care in Calif.; nurses' authority in Minn.

A selection of health policy stories from California, Minnesota, Georgia, Washington state, Louisiana, Michigan, North Carolina, Illinois and Maryland. [More]
Scientist wins 2014 Maurice Hilleman/Merck Award for developing vaccine against meningococcal disease

Scientist wins 2014 Maurice Hilleman/Merck Award for developing vaccine against meningococcal disease

Dan Granoff, MD, of UCSF Benioff Children's Hospital Oakland's research arm CHORI, has been named the 2014 Maurice Hilleman/Merck Award Laureate by the American Society for Microbiology (ASM). [More]
Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex Corporation today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™. [More]
Global market for meningococcal vaccines expected to grow at CAGR of 14.9% from 2013 to 2019

Global market for meningococcal vaccines expected to grow at CAGR of 14.9% from 2013 to 2019

According to a new report published by Transparency Market Research "Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the market for meningococcal vaccines was valued at USD 1.5 billion in 2012 and is expected to reach a value of USD 3.7 billion in 2019, growing at a CAGR of 14.9% from 2013 to 2019. [More]
Humana's profit shrinks on higher expenses

Humana's profit shrinks on higher expenses

The insurer said it expects to add more customers to its Medicare Advantage and individual plan businesses. Meanwhile, a few hospitals say they are doing simple surgeries for some uninsured patients for free to keep their problems from turning into emergencies that would be more expensive to treat, and those who developed meningitis as a result of tainted products seek compensation. [More]
First Edition: May 7, 2014

First Edition: May 7, 2014

Today's headlines include a story noting that insurers say about 80 percent of new enrollees have paid their first premiums for new insurance coverage under the health law. [More]
Researchers discover genetic risk factor for premature birth

Researchers discover genetic risk factor for premature birth

Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth. [More]
Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3. [More]
Research roundup: Compounding pharmacies; marketplace details; changes in insurance coverage

Research roundup: Compounding pharmacies; marketplace details; changes in insurance coverage

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 sickened, Congress passed the Compounding Quality Act . [More]
Roundup: Battles fought over Lyme disease, autism and abortion

Roundup: Battles fought over Lyme disease, autism and abortion

In Texas, abortion providers file suit to block a state rule that could shut down many of the state's remaining clinics, while lawmakers in Vermont and N.Y. seek to immunize doctors who prescribe long-term antibiotics for patients with lasting symptoms attributed to Lyme disease. [More]
First Edition: April 3, 2014

First Edition: April 3, 2014

Today's headlines include reports on how Paul Ryan's budget is playing on Capitol Hill as well as news that the Obama administration is releasing a trove of data on physician services and payments. [More]
New cluster of viral meningitis cases found among Los Angeles area gay men

New cluster of viral meningitis cases found among Los Angeles area gay men

In response to reports of a new cluster of viral meningitis cases found among Los Angeles area gay men and men-who-have-sex-with-men (MSM), Los Angeles County Public Health Department officials are expected to release an official statement later today in which they will recommend that HIV-positive MSM and high-risk HIV-negative MSM be vaccinated against the infection. [More]
Low dose injections of artificial properdin provides protection against septic diseases in mice

Low dose injections of artificial properdin provides protection against septic diseases in mice

Breakthrough MRC-funded study from University of Leicester shows low dose injections of artificial properdin provides substantial protection against septic diseases in mice [More]
Low dose injections of artificial properdin provide protection against septic diseases

Low dose injections of artificial properdin provide protection against septic diseases

Researchers at the University of Leicester have produced an artificial version of a naturally occurring protein, properdin, which has been found to successfully combat bacterial pneumonia and meningitis when tested in mice. [More]